Dowd Scheffel Files Amicus Brief for The Honorable Paul R. Michel (Ret.) in Important § 101 Patent-Eligibility Appeal
- Matthew Dowd
- May 17, 2024
- 1 min read
Dowd Scheffel recently filed an amicus curiae brief on behalf of the Honorable Paul. R. Michel (ret.), the former chief judge of the U.S. Court of Appeals for the Federal Circuit. The amicus brief was filed in an appeal from a Delaware district court’s decision in the Regenxbio Inc. v. Sarepta Therapeutics, Inc. case. The district court decided that the claimed genetically engineered cells are not patent-eligible under § 101. As the amicus brief explains, “[t]his is an easy case,” identifying several flaws in the district court’s reasoning. The amicus brief also details how “it is not possible to reconcile the district court’s holding with the Supreme Court’s ruling in [Diamond v.] Chakrabarty,” the seminal 1980 decision which confirmed that genetically engineered bacteria are eligible for patent protection. The brief is linked below.
When planning a trip to Morocco, I realized that the real challenge isn’t choosing where to go, but how to experience each place without feeling rushed or disconnected. During my research, I found luxury Morocco tours by Sun Trails and it helped me better understand the value of a well-paced itinerary that allows time to actually enjoy each stop. I’ve had trips before where everything felt too scheduled, leaving little room to appreciate the atmosphere or the local culture. What I found interesting here is the focus on balance, making sure that comfort and exploration can coexist without one taking over the other. It definitely changed the way I think about organized travel.